ELLPMDA: Ensemble learning and link prediction for miRNA-disease association prediction

References

• Bartel DP. MicroRNAs.: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281–97.
   PubMed Web of Science ®Google Scholar
• Cheng AM, Byrom MW, Shelton J, et al.. Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res. 2005;33(4):1290–7.
   PubMed Web of Science ®Google Scholar
• Karp X, Ambros V. Encountering microRNAs in cell fate signaling. Science. 2005;310(5752):1288–9.
   PubMed Web of Science ®Google Scholar
• Miska EA. How microRNAs control cell division, differentiation and death. Curr Opin Genetics Dev. 2005;15(5):563–8.
   PubMed Web of Science ®Google Scholar
• Xu P, Guo M, Hay BA. MicroRNAs and the regulation of cell death. Trends Genetics. 2004;20(12):617–24.
   PubMed Web of Science ®Google Scholar
• Alshalalfa M, Alhajj R. Using context-specific effect of miRNAs to identify functional associations between miRNAs and gene signatures. BMC Bioinformatics. 2013;14(12):S1.
   PubMedGoogle Scholar
• Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136(2):215–33.
   PubMed Web of Science ®Google Scholar
• Cui Q, Yu Z, Purisima EO, et al.. Principles of microRNA regulation of a human cellular signaling network. Mol Systems Biol. 2006;2(1):46.
   PubMedGoogle Scholar
• Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993;75(5):843–54.
   PubMed Web of Science ®Google Scholar
• Wightman B, Ha I, Ruvkun G. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell. 1993;75(5):855–62.
   PubMed Web of Science ®Google Scholar
• Griffiths-Jones S, Grocock RJ, Van Dongen S, Bateman A, et al.. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res. 2006;34(suppl 1):D140–D4.
   PubMedGoogle Scholar
• Kozomara A, Griffiths-Jones S. miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res. 2010;39(Database issue):gkq1027.
   Google Scholar
• Ambros V. The functions of animal microRNAs. Nature. 2004;431(7006):350–5.
   PubMed Web of Science ®Google Scholar
• He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genetics. 2004;5(7):522–31.
   PubMed Web of Science ®Google Scholar
• Esquela-Kerscher A, Slack FJ. Oncomirs—microRNAs with a role in cancer. Nat Rev Cancer. 2006;6(4):259–69.
   PubMed Web of Science ®Google Scholar
• Yu Z, Li Z, Jolicoeur N, et al.. Aberrant allele frequencies of the SNPs located in microRNA target sites are potentially associated with human cancers. Nucleic Acids Res. 2007;35(13):4535–41.
   PubMed Web of Science ®Google Scholar
• Strillacci A, Griffoni C, Sansone P, et al.. MiR-101 downregulation is involved in cyclooxygenase-2 overexpression in human colon cancer cells. Exp Cell Res. 2009;315(8):1439–47.
   PubMed Web of Science ®Google Scholar
• Yang H, Kong W, He L, et al.. MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Res. 2008;68(2):425–33.
   PubMed Web of Science ®Google Scholar
• Liu C, Kelnar K, Liu B, et al.. The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat Med. 2011;17(2):211–5.
   PubMed Web of Science ®Google Scholar
• Bonci D, Coppola V, Musumeci M, et al.. The miR-15a–miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. Nat Med. 2008;14(11):1271–7.
   PubMed Web of Science ®Google Scholar
• Chen X, Yan CC, Zhang X, et al.. HGIMDA: Heterogeneous graph inference for miRNA-disease association prediction. Oncotarget. 2016;7(40):65257–69.
   PubMedGoogle Scholar
• Li J-Q, Rong Z-H, Chen X, et al.. MCMDA: Matrix completion for MiRNA-disease association prediction. Oncotarget. 2017;8(13):21187–21199
   PubMedGoogle Scholar
• Chen X, Yan CC, Zhang X, et al.. RBMMMDA: predicting multiple types of disease-microRNA associations. Scientific Reports. 2015;5:13877.
   PubMed Web of Science ®Google Scholar
• Chen X, Yan G-Y. Semi-supervised learning for potential human microRNA-disease associations inference. Scientific Reports. 2014;4:5501.
   PubMed Web of Science ®Google Scholar
• Chen X, Liu M-X, Yan G-Y. RWRMDA: predicting novel human microRNA–disease associations. Mol BioSystems. 2012;8(10):2792–8.
   PubMed Web of Science ®Google Scholar
• Chen X, Liu M-X, Cui Q-H, et al.. Prediction of disease-related interactions between microRNAs and environmental factors based on a semi-supervised classifier. PloS One. 2012;7(8):e43425.
   PubMed Web of Science ®Google Scholar
• Chen X. KATZLDA: KATZ measure for the lncRNA-disease association prediction. Scientific Reports. 2015;5:16840.
   PubMed Web of Science ®Google Scholar
• Chen X, Yan CC, Zhang X, et al.. WBSMDA: within and between score for MiRNA-disease association prediction. Scientific Reports. 2016;6:21106.
   PubMed Web of Science ®Google Scholar
• Xuan P, Han K, Guo M, et al.. Prediction of microRNAs associated with human diseases based on weighted k most similar neighbors. PloS One. 2013;8(8):e70204.
   PubMed Web of Science ®Google Scholar
• Jiang Q, Hao Y, Wang G, et al.. Prioritization of disease microRNAs through a human phenome-microRNAome network. BMC Sys Biol. 2010;4(1):S2.
   PubMedGoogle Scholar
• Bandyopadhyay S, Mitra R, Maulik U, et al.. Development of the human cancer microRNA network. Silence. 2010;1(1):6.
   PubMedGoogle Scholar
• Wang D, Wang J, Lu M, et al.. Inferring the human microRNA functional similarity and functional network based on microRNA-associated diseases. Bioinformatics. 2010;26(13):1644–50.
   PubMed Web of Science ®Google Scholar
• Goh K-I, Cusick ME, Valle D, et al.. The human disease network. Proc Natl Acad Sci. 2007;104(21):8685–90.
   PubMed Web of Science ®Google Scholar
• Pasquier C, Gardès J. Prediction of miRNA-disease associations with a vector space model. Scientific Reports. 2016;6:27036.
   PubMed Web of Science ®Google Scholar
• Shi H, Xu J, Zhang G, et al.. Walking the interactome to identify human miRNA-disease associations through the functional link between miRNA targets and disease genes. BMC Systems Biol. 2013;7(1):101.
   PubMedGoogle Scholar
• Xu C, Ping Y, Li X, et al.. Prioritizing candidate disease miRNAs by integrating phenotype associations of multiple diseases with matched miRNA and mRNA expression profiles. Mol BioSystems. 2014;10(11):2800–9.
   PubMed Web of Science ®Google Scholar
• Mørk S, Pletscher-Frankild S, Caro AP, et al.. Protein-driven inference of miRNA–disease associations. Bioinformatics. 2013;30(3):btt677.
   Web of Science ®Google Scholar
• Xuan P, Han K, Guo Y, et al.. Prediction of potential disease-associated microRNAs based on random walk. Bioinformatics. 2015;31(11):btv039.
   Web of Science ®Google Scholar
• Yang Z, Ren F, Liu C, et al.. dbDEMC: a database of differentially expressed miRNAs in human cancers. BMC Genomics. 2010;11(4):S5.
   PubMedGoogle Scholar
• Jiang Q, Wang Y, Hao Y, et al.. miR2Disease: a manually curated database for microRNA deregulation in human disease. Nucleic Acids Res. 2009;37(suppl 1):D98–D104.
   PubMedGoogle Scholar
• Li Y, Qiu C, Tu J, et al.. HMDD v2. 0: a database for experimentally supported human microRNA and disease associations. Nucleic Acids Res. 2014;42(D1):D1070–D4.
   PubMed Web of Science ®Google Scholar
• Oved K, Morag A, Pasmanik-Chor M, et al.. Genome-wide miRNA expression profiling of human lymphoblastoid cell lines identifies tentative SSRI antidepressant response biomarkers. Pharmacogenomics. 2012;13(10):1129–39.
   PubMed Web of Science ®Google Scholar
• Drusco A, Nuovo GJ, Zanesi N, et al.. MicroRNA profiles discriminate among colon cancer metastasis. PloS One. 2014;9(6):e96670.
   PubMed Web of Science ®Google Scholar
• Ogata-Kawata H, Izumiya M, Kurioka D, et al.. Circulating exosomal microRNAs as biomarkers of colon cancer. PloS One. 2014;9(4):e92921.
   PubMed Web of Science ®Google Scholar
• Jemal A, Bray F, Center MM, et al.. Global cancer statistics. CA: Cancer J Clin. 2011;61(2):69–90.
   PubMed Web of Science ®Google Scholar
• Guo C, Sah JF, Beard L, et al.. The noncoding RNA, miR‐126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3‐kinase signaling and is frequently lost in colon cancers. Genes Chromosomes Cancer. 2008;47(11):939–46.
   PubMed Web of Science ®Google Scholar
• Nakajima G, Hayashi K, Xi Y, et al.. Non-coding MicroRNAs hsa-let-7g and hsa-miR-181b are associated with Chemoresponse to S-1 in colon cancer. Cancer Genomics-Proteomics. 2006;3(5):317–24.
   PubMedGoogle Scholar
• Shi B, Sepp-Lorenzino L, Prisco M, et al.. Micro RNA 145 targets the insulin receptor substrate-1 and inhibits the growth of colon cancer cells. J BiolChem. 2007;282(45):32582–90.
   PubMed Web of Science ®Google Scholar
• Volinia S, Calin GA, Liu C-G, et al.. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natal Acad Sci U S A. 2006;103(7):2257–61.
   PubMed Web of Science ®Google Scholar
• Asangani I, Rasheed S, Nikolova D, et al.. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene. 2008;27(15):2128–36.
   PubMed Web of Science ®Google Scholar
• Pu Xx, Huang GL, Guo HQ, et al.. Circulating miR‐221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression. J Gastroenterol Hepatol. 2010;25(10):1674–80.
   PubMed Web of Science ®Google Scholar
• Nishida N, Yokobori T, Mimori K, et al.. MicroRNA miR-125b is a prognostic marker in human colorectal cancer. Int J Oncol. 2011;38(5):1437.
   PubMed Web of Science ®Google Scholar
• He B, Yin B, Wang B, et al.. microRNAs in esophageal cancer (Review). Mol Med Reports. 2012;6(3):459–65.
   PubMed Web of Science ®Google Scholar
• Enzinger PC, Mayer RJ. Esophageal cancer. N Eng J Med. 2003;349(23):2241–52.
   PubMed Web of Science ®Google Scholar
• Lee K-H, Goan Y-G, Hsiao M, et al.. MicroRNA-373 (miR-373) post-transcriptionally regulates large tumor suppressor, homolog 2 (LATS2) and stimulates proliferation in human esophageal cancer. Exp Cell Res. 2009;315(15):2529–38.
   PubMed Web of Science ®Google Scholar
• Zhang H, Li M, Han Y, et al.. Down-regulation of miR-27a might reverse multidrug resistance of esophageal squamous cell carcinoma. Digestive Dis Sci. 2010;55(9):2545–51.
   PubMed Web of Science ®Google Scholar
• Yu X, Jiang X, Li H, et al.. miR-203 inhibits the proliferation and self-renewal of esophageal cancer stem-like cells by suppressing stem renewal factor Bmi-1. Stem Cells Dev. 2013;23(6):576–85.
   Web of Science ®Google Scholar
• Jemal A, Siegel R, Ward E, et al.. Cancer statistics, 2006. CA: Cancer J Clin. 2006;56(2):106–30.
   PubMed Web of Science ®Google Scholar
• Manojlović D, Elaković D, Mladenović L. Therapeutic value of transcatheter embolization in malignant tumors of the renal parenchyma. Srpski Arhiv Za Celokupno Lekarstvo. 1986;114(7):631–7.
   PubMedGoogle Scholar
• Takehara K, Nishikido M, Koga S, et al.. Multifocal transitional cell carcinoma associated with renal cell carcinoma in a patient on long‐term haemodialysis. Nephrol Dialysis Transplantation. 2002;17(9):1692–4.
   PubMed Web of Science ®Google Scholar
• Abdelmohsen K, Kim MM, Srikantan S, et al.. miR-519 suppresses tumor growth by reducing HuR levels. Cell Cycle. 2010;9(7):1354–9.
   PubMed Web of Science ®Google Scholar
• Mikhaylova O, Stratton Y, Hall D, et al.. VHL-regulated MiR-204 suppresses tumor growth through inhibition of LC3B-mediated autophagy in renal clear cell carcinoma. Cancer Cell. 2012;21(4):532–46.
   PubMed Web of Science ®Google Scholar
• Nakada C, Tsukamoto Y, Matsuura K, et al.. Overexpression of miR‐210, a downstream target of HIF1α, causes centrosome amplification in renal carcinoma cells. J Pathol. 2011;224(2):280–8.
   PubMed Web of Science ®Google Scholar
• Tsz-fung FC, Mankaruos M, Scorilas A, et al.. The miR-17-92 cluster is over expressed in and has an oncogenic effect on renal cell carcinoma. J Urol. 2010;183(2):743–51.
   PubMed Web of Science ®Google Scholar
• Lu R, Ji Z, Li X, et al.. miR-145 functions as tumor suppressor and targets two oncogenes, ANGPT2 and NEDD9, in renal cell carcinoma. J Cancer Res Clin Oncol. 2014;140(3):387–97.
   PubMed Web of Science ®Google Scholar
• Bai X-Y, Ma Y, Ding R, et al.. miR-335 and miR-34a Promote renal senescence by suppressing mitochondrial antioxidative enzymes. J Am Soc Nephrol. 2011;22(7):1252–61.
   PubMed Web of Science ®Google Scholar
• Thai T-H, Calado DP, Casola S, et al.. Regulation of the germinal center response by microRNA-155. Science. 2007;316(5824):604–8.
   PubMed Web of Science ®Google Scholar
• Yang M, Shen H, Qiu C, et al.. High expression of miR-21 and miR-155 predicts recurrence and unfavourable survival in non-small cell lung cancer. Eur J Cancer. 2013;49(3):604–15.
   PubMed Web of Science ®Google Scholar
• Yuxia M, Zhennan T, Wei Z. Circulating miR-125b is a novel biomarker for screening non-small-cell lung cancer and predicts poor prognosis. J Cancer Res Clin Oncol. 2012;138(12):2045–50.
   PubMed Web of Science ®Google Scholar
• Osada H, Takahashi T. let‐7 and miR‐17‐92: Small‐sized major players in lung cancer development. Cancer Sci. 2011;102(1):9–17.
   PubMed Web of Science ®Google Scholar
• Hayashita Y, Osada H, Tatematsu Y, et al.. A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res. 2005;65(21):9628–32.
   PubMed Web of Science ®Google Scholar
• Zhang C, Zhang J, Zhang A, et al.. PUMA is a novel target of miR-221/222 in human epithelial cancers. Int J Oncol. 2010;37(6):1621.
   PubMed Web of Science ®Google Scholar
• Tao Z, Shi A, Lu C, et al.. Breast cancer: epidemiology and etiology. Cell Biochem Biophys. 2015;72(2):333–8.
   PubMed Web of Science ®Google Scholar
• Yan L-X, Huang X-F, Shao Q, et al.. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. Rna. 2008;14(11):2348–60.
   PubMed Web of Science ®Google Scholar
• Hossain A, Kuo MT, Saunders GF. Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA. Mol Cell Biol. 2006;26(21):8191–201.
   PubMed Web of Science ®Google Scholar
• Wang H, Tan G, Dong L, et al.. Circulating MiR-125b as a marker predicting chemoresistance in breast cancer. PloS One. 2012;7(4):e34210.
   PubMed Web of Science ®Google Scholar
• Camps C, Buffa FM, Colella S, et al.. hsa-miR-210 Is induced by hypoxia and is an independent prognostic factor in breast cancer. Clin Cancer Res. 2008;14(5):1340–8.
   PubMed Web of Science ®Google Scholar
• Cloutier M, Wang E. Dynamic modeling and analysis of cancer cellular network motifs. Integrative Biol. 2011;3(7):724–32.
   PubMed Web of Science ®Google Scholar
• Wang E, Zaman N, Mcgee S, et al.. editors. Predictive genomics: a cancer hallmark network framework for predicting tumor clinical phenotypes using genome sequencing data. Semin Cancer Biol. 2015;30:4–12. Elsevier
   Google Scholar
• van Laarhoven T, Nabuurs SB, Marchiori E. Gaussian interaction profile kernels for predicting drug–target interaction. Bioinformatics. 2011;27(21):3036–43.
   PubMed Web of Science ®Google Scholar
• Jaccard P. Etude de la distribution florale dans une portion des Alpes et du Jura. Bulletin De La Societe Vaudoise Des Sciences Naturelles. 1901;37(142):547–79.
   Google Scholar
• Katz L. A new status index derived from sociometric analysis. Psychometrika. 1953;18(1):39–43.
   Google Scholar
• Lü L, Zhou T. Link prediction in complex networks: A survey. Physica A: Statistical Mechan Applications. 2011;390(6):1150–70.
   Web of Science ®Google Scholar
• Chen X, Huang Y-A, You Z-H, et al.. A novel approach based on KATZ measure to predict associations of human microbiota with non-infectious diseases. Bioinformatics. 2016;33(5):btw715.
   Web of Science ®Google Scholar